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Calf muscle hemoglobin oxygen saturation in
patients with peripheral artery disease who have
different types of exertional leg pain
Andrew W. Gardner, PhD,a,b Donald E. Parker, PhD,c Polly S. Montgomery, MS,a
Aman Khurana, MDb,d Raphael M. Ritti-Dias, PhD,e and Steve M. Blevins, MD,f Oklahoma City, Okla;
and Pernambuco, Brazil
Background: This study compared calf muscle hemoglobin oxygen saturation (StO2) and exercise performance during
standardized treadmill exercise in patients with peripheral artery disease (PAD) who describe different types of exertional
leg pain and compared secondary outcomes consisting of daily ambulatory activity and exercise performance during a
6-minute walk test (6MWT).
Methods: Leg pain symptoms were evaluated in 114 patients with PAD using the San Diego Claudication Questionnaire,
by which atypical exertional leg pain was defined in 31, claudication in 37, and leg pain on exertion and rest in 46. Patients
were evaluated on a standardized, graded treadmill test during which calf muscle StO2 was continuously monitored. The
6MWT distance, Walking Impairment Questionnaire (WIQ), and ambulatory activity were monitored during 1 week.
Results: All patients experienced symptoms during the treadmill test consistent with claudication. The groups were not
significantly different on the primary outcomes of time to reach the minimum calf muscle StO2 (P .350) or peak walking
time (P  .238) during treadmill exercise. Patients with atypical leg pain had the highest daily ambulatory activity for
total strides per day (P  .032), average daily cadence (P  .010), maximum cadences for durations between 5 minutes
(P .035) and 60 minutes (P .029), speed score on the WIQ (P .006), and lowest rating of perceived exertion at the
end of the 6MWT (P  .017).
Conclusions: PAD patients with atypical leg pain have vascular-mediated limitations in exercise performance during
standardized treadmill testing similar to patients with claudication and patients with leg pain on exertion and rest but
have higher levels of daily ambulatory activity in the community setting and higher perceived ambulatory function.
(J Vasc Surg 2012;55:1654-61.)
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tPeripheral artery disease (PAD) is prevalent in12% of
the United States population aged 65 years1 and is asso-
ciated with increased prevalence of cardiovascular disease
risk factors1,2 and increased coprevalence of disease in the
coronary, cerebral, and renal arteries.1,2 More than 60% of
those with PAD have concomitant cardiovascular or cere-
brovascular disease, or both,2 thereby contributing to their
elevated rates of mortality.3,4 In addition to having high
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1654ardiovascular risk, many of those with PAD are physically
imited by ambulatory leg pain that results in impaired
mbulation,5,6 reduced physical function,7,8 and lower
aily physical activity.9,10
On initial clinical presentation, 10% to 35% of patients
ith PAD report claudication symptoms, and 30% to 50%
eport other leg pain that is atypical of the classic descrip-
ion of claudication.1,2 When PAD patients with different
ypes of exertional leg pain are compared, patients with
laudication have worse functional status, self-reported am-
ulatory function, and health-related quality of life than
atients with atypical pain11 but have better values than
hose reporting leg pain on exertion and rest.7,11 We re-
ently found that regardless of the type of leg pain reported,
ll patients experienced symptoms during a standardized
readmill test consistent with classic claudication,12 indicat-
ng the limitations associated with descriptions of leg pain
uring the initial clinical presentation. Furthermore, pa-
ients with different types of exertional leg pain were re-
arkably similar on claudication onset time (COT) and
eak walking time (PWT) during treadmill exercise, and on
he ankle-brachial index (ABI) and ischemic window.12
Calf muscle hemoglobin oxygen saturation (StO2), a
easure of the microcirculation in the musculature during
xercise, is highly associated with COT and PWT,13,14 and
his association persists even after adjusting for ABI.14 As
uch, differences in the microcirculation may partially ex-
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Volume 55, Number 6 Gardner et al 1655plain the different descriptions of leg pain. However, calf
muscle StO2 in PAD patients with different types of exer-
tional leg pain has not been examined.
The primary purpose of this study was to compare calf
muscle StO2 and exercise performance during standardized
treadmill exercise in patients with PAD who describe dif-
ferent types of exertional leg pain. An additional aim was to
compare secondary outcomes, consisting of daily ambula-
tory activity and exercise performance during a 6-minute
walk test (6MWT), among the groups with exertional leg
pain. We hypothesized that the group with leg pain on
exertion and rest would have the most impaired calf muscle
StO2 during treadmill exercise, and the lowest 6MWT
distance and daily ambulatory activity.
METHODS
Patients
The procedures used in this study were approved by the
Institutional Review Board at the University of Oklahoma
Health Sciences Center (HSC) and by the Research and
Development committee at the Oklahoma City VA Medi-
cal Center. Written informed consent was obtained from
each patient before investigation.
Recruitment. Patients were recruited by referrals from
vascular and primary care clinics from the University of
Oklahoma HSC and the Oklahoma City VA Medical Cen-
ter, and by newspaper advertisements for possible enroll-
ment into a randomized controlled exercise rehabilitation
study for the treatment of leg pain secondary to PAD.15
The data and analyses for this study were part of the
baseline assessments obtained for the exercise study. A
consecutive series of 174 individuals were evaluated for
study eligibility in the General Clinical Research Center
(GCRC) at the University of Oklahoma HSC.
Medical screening. Patients arrived at the GCRC in
the morning fasted, but were permitted to take their usual
morning medication regimen. Demographic information,
height, weight, cardiovascular risk factors, comorbid con-
ditions, claudication history, blood samples, and a list of
current medications were obtained from a medical history
and physical examination at the beginning of the study.
During the physical examination, arterial oxygen saturation
was measured from the index finger using a standard pulse
oximeter. Subcutaneous fat over the medial gastrocnemius
muscle was measured from a skinfold using a Lange skin-
fold caliper according to standard guidelines,16 and waist
circumference was recorded using a plastic measuring
tape.16
Inclusion and exclusion criteria. Patients with PAD
were included in this study if they met the following crite-
ria: (1) a history of any type of exertional leg pain, (2)
ambulatory leg pain confirmed during a graded treadmill
test,5 and (3) an ABI0.90 at rest1 or an ABI0.73 after
exercise, because some PAD patients have normal values at
rest that only become abnormal after an exercise test.17
Exclusion criteria were (1) absence of PAD (ABI
0.90 at rest and ABI0.73 after exercise), (2) inability to rbtain an ABI measure due to noncompressible vessels, (3)
symptomatic PAD determined from the medical history
nd verified during the graded treadmill test, (4) use of
edications indicated for the treatment of intermittent
laudication (cilostazol and pentoxifylline) initiated 3
onths before the investigation, (5) exercise tolerance
imited by any disease process other than PAD, (6) active
ancer, (7) kidney failure defined as stage 5 chronic kidney
isease, (8) abnormal liver function, (9) calf skinfold 50
m because of potential interference with the light path of
he near infrared spectrometer probe from penetrating the
ubcutaneous tissue, and (10) pulse arterial oxygen satura-
ion of the index finger 95% because of the potential
eleterious effect on calf muscle StO2 from poor pulmonary
as exchange. A total of 174 patients were evaluated for this
tudy, and 114 were deemed eligible.
Groups with exertional leg symptoms. Leg symp-
oms were evaluated by administering the San Diego Clau-
ication Questionnaire (SDCQ),18 a standardized and
alidated 11-item questionnaire based on the Rose ques-
ionnaire for intermittent claudication.19 According to the
esponses from the SDCQ, PAD patients were placed into
ne of the following exertional leg symptom groups:
. Atypical exertional leg pain group (n  31), defined as
leg pain on exertion that does not cause the patient to
stop or slow down (9 of the 31 patients) or pain that
does cause the patient to stop or slow down but does not
fulfill the remaining criteria for claudication (22 of the
31 patients),
. Claudication group (n  37), defined as leg pain on
exertion that causes the patient to stop or slow down, is
located in the calves, does not resolve while walking, and
goes away within 10 minutes of rest, and
. Leg pain on exertion and rest group (n 46), defined
as leg pain on exertion that sometimes begins at
rest.7,11,20-22
rimary outcome measures
Calf muscle Sto2, COT, PWT, and ischemic win-
ow obtained during the graded treadmill test. Pa-
ients performed a progressive, graded treadmill protocol
o determine study eligibility as well as to obtain outcome
easures related to peak exercise performance.5 The COT,
easured as the walking time at which the patient first
xperienced pain, and the PWT, measured as the walking
ime at which ambulation could not continue due to max-
mal pain, were recorded to quantify the severity of
laudication.
Peak oxygen uptake was measured by oxygen uptake
btained during the peak exercise workload with a Medical
raphics VO2000 metabolic system (Medical Graphics
nc, St. Paul, Minn). The test–retest intraclass reliability
oefficient with these procedures isR .89 for COT,5R
93 for PWT,5 and R  .88 for peak oxygen uptake.23
Calf muscle StO2 was measured before, during, and
fter the treadmill test using a continuous-wave, near infra-
ed spectrometer unit (InSpectra model 325; Hutchinson
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June 20121656 Gardner et alTechnology Inc, Hutchinson, Minn), an optical cable at-
tached to a 25-mm probe, InSpectra 2.0 software, and a
dedicated laptop computer as previously described.13 The
probe was attached to the skin over the medial gastrocne-
mius muscle of the more severely affected leg using a
double-sided adhesive light-excluding patch.24 A baseline
measure of calf muscle StO2 was obtained at rest as patients
stood on the treadmill for 2 minutes to allow for equilibra-
tion. From the start of treadmill exercise, the minimum
StO2 value, the time taken to reach the minimum value, the
absolute and percentage drops in calf muscle StO2 from rest
to the minimum exercise value, the average rate of decline
from rest to the minimum exercise value, and the calf
muscle StO2 at PWT were obtained. The recovery times for
StO2 to reach one-half of the resting StO2 value (recovery
half-time), to reach the full resting StO2 value (recovery
time), and to reach the maximum StO2 value were calcu-
lated by subtracting the time to end of exercise from the
time the recovery StO2 values were observed.
As in our previous investigations,13,14 we attempted to
calculate tau using exponential models for StO2 data.
25
However, the individual graphs of the time course of StO2
during exercise did not fit this kinetic model for calculating
tau. As such, we calculated the parameters described above
because they are easily obtained metrics that do not require
prior assumptions. In addition to their clinical utility, par-
ticularly the strong association between the time to mini-
mum calf muscle StO2 with COT and PWT,
13,14 we also
have found that calf muscle StO2 measures can be reliably
obtained during and after exercise. Reliability of these
measures was assessed in 110 patients who performed the
progressive, graded treadmill protocol twice in our labora-
tory. The test–retest intraclass reliability coefficient was
R  .85 for calf muscle StO2 obtained at rest, R  .91 for
the minimum value obtained during exercise, R  .86 for
the time to reach the minimum calf muscle StO2 value
during exercise, and between R .81 and R .91 for the
remaining calf muscle StO2 measures obtained during and
after exercise.
ABI measures were obtained from the more severely
diseased lower extremity before and at 1, 3, 5, and 7
minutes after the treadmill test.5,23 The reduction in ankle
systolic blood pressure after treadmill exercise from the
resting baseline value was quantified by calculating the area
under the curve, referred to as the ischemic window.26
Because the ischemic window is a function of PAD severity
and also the amount of exercise performed, the ischemic
window was normalized per meter walked.
Secondary outcome measures
Walking Impairment Questionnaire. Self-reported
ambulatory ability was assessed using the Walking Impair-
ment Questionnaire (WIQ), a validated questionnaire for
PAD patients that assesses ability to walk at various speeds
and distances and to climb stairs.27
6-Minute walk test. Patients performed an over-the-
ground 6MWT supervised by trained exercise techni-
cians.28 The pain-free and total distance walked during the best was recorded. The test–retest intraclass reliability coef-
cient isR .75 for distance to onset of claudication pain,
nd R  .94 for total 6MWT distance.28
Ambulatory activity monitoring. Daily ambulatory
ctivity was assessed using the StepWatch3 step activity
onitor (Orthoinnovations Inc, Oklahoma City, Okla), as
reviously described.29 Ambulatory activity was measured
or 7 consecutive days in which patients were instructed to
ear the monitor during waking hours and to remove it
efore retiring to bed and while showering. The step activ-
ty monitor was attached to the right ankle above the lateral
alleolus using an elastic Velcro strap and continuously
ecorded the number of strides taken each day and the
umber of minutes spent ambulating each day. The daily
mbulatory strides and time were further analyzed by the
oftware program and quantified into the following vari-
bles:
● Maximum cadence for 60, 30, 20, and 5 continuous
minutes of ambulation each day,
● Maximum cadence for 1 minute of ambulation each
day (ie, the minute with the highest cadence value each
day), and
● Peak activity index obtained by ranking all minutes of
the day according to cadence and then taking the
highest 30 values.
These outcome measures were recorded and averaged
or each day, and then the daily averages were averaged over
he 7-day monitoring period. The accuracy of the step
ctivity monitor exceeds 99%  1% in patients with claudi-
ation,29 and the test–retest intraclass reliability coefficient
or the daily ambulatory activity measures ranges fromR
83 to R  .94.29
tatistical analyses
Means of all measurement variables were compared
mong the three groups using a one-way analysis of vari-
nce, and where significance (P  .05) was observed, a
ukey-Kramer multicomparison test among the three
eans was conducted. For the primary outcome variables,
5% confidence intervals (95% CI) were calculated for the
ifference from the claudication group mean and the mean
f each of other two groups. For these sample sizes, the
ower was approximately 95% for effect size of .37 and 80%
or effect size of .29, indicating that this study was more
han adequately powered to detect rather small effect size
ifferences among groups for the time to minimum calf
uscle StO2. The proportions for the dichotomous vari-
bles were tested for differences using two-degree of free-
om 2 test. All calculations and power analysis were made
sing NCSS 2000 software (NCSS, Kaysville, Utah).
ESULTS
Clinical characteristics. Patients with PAD were clas-
ified into three groups according to their type of exertional
eg pain. The clinical characteristics of these groups are
eported in Table I. Groups were significantly different on
ody mass index (P .018), ABI (P .002), prevalence of
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Volume 55, Number 6 Gardner et al 1657obesity (P  .009), and prevalence of abdominal obesity
(P  .030). The group with leg pain on exertion and rest
had the highest values, and the claudication group had the
lowest values. The groups were not significantly different
(P  .05) on all remaining variables.
Primary outcome measures. The exercise measures
of each group during the treadmill test are reported in
Table II. All patients experienced symptoms during the
treadmill test consistent with claudication. The groups
were not significantly different (P  .05) on any of the
exercise performance measures or on any of the calf muscle
StO2 measures. Of particular importance, the time to reach
the minimum calf muscle StO2 value during exercise was
remarkably similar among the groups (P .350). The 95%
CI comparing the time to minimum calf muscle StO2
between those with atypical exertional leg pain and those
with claudication was 34 to 200 seconds, indicating that
the group difference for the populations of inference is
within 4 minutes during the treadmill test (equivalent to
two exercise stages). An even smaller 95%CI of120 to 77
seconds was noted for the comparison between those with
claudication and those with leg pain on exertion and rest,
indicating that the group difference for the population of
Table I. Clinical characteristics of patients with peripheral
groups
Variablesa
Atypical leg pain
(n  31)
Age, years 66 (9)
Weight, kg 85 (19)
Body mass index, kg/m2 29.0 (5.9)
Ankle-brachial index 0.69 (0.22)
Male sex 55
White race 45
Current smoking 39
Hypertension 84
Medication use 74
Medications taken, No. 2.3 (1.1)
Dyslipidemia 71
Medication use 58
Medications taken, No. 1.4 (1.0)
Diabetes 39
Medication use 36
Medications taken, No. 1.6 (0.7)
Abdominal obesity 58
Metabolic syndrome 74
Metabolic syndrome components, No. 3.4 (1.5)
Obesity 42
Lower extremity revascularization 36
Coronary artery disease 19
Myocardial infarction 7
Cerebrovascular disease 13
Cerebrovascular accident 13
Renal disease 10
Chronic obstructive pulmonary disease 23
Dyspnea 48
aValues are means (standard deviation) and percentage “yes.”
bDifferent than claudication group (P  .05).inference is within 3 minutes. CSecondary outcome measures. The 6MWT perfor-
ance, daily ambulatory activity, and walking impairment
uestionnaire measures are reported in Table III. Patients
ith atypical exertional leg pain reported the lowest rating
f perceived exertion at the end of the 6MWT(P  .017).
atients with atypical exertional leg pain also had the high-
st daily ambulatory activity measures for total strides per
ay (P  .032), peak activity index (P  .040), average
aily cadence (P  .010), and maximum cadences for
urations of 5 (P  .035), 20 (P  .007), 30 (P  .020),
nd 60 minutes (P  .029). Patients with atypical exer-
ional leg pain also reported the highest speed score on the
IQ (P  .006).
ISCUSSION
ovel findings: calf muscle Sto2
The novel finding of this investigation is that calf mus-
le StO2 variables were not significantly different among the
roups with exertional leg pain during standardized tread-
ill exercise. A key measure of calf muscle StO2 during
xercise is the observed time to reach the minimum StO2
alue because this measure is positively associated with
ry disease (PAD) placed in three exertional leg symptom
Group
Claudication
(n  37)
Leg pain on exertion and rest
(n  46) P
65 (11) 62 (10) .218
81 (20) 89 (19) .142
28.4 (5.7) 32.0 (6.4)b .018
0.63 (0.20) 0.81 (0.28)b .002
60 48 .564
49 46 .603
50 33 .277
89 85 .785
87 87 .277
2.6 (1.1) 2.4 (1.0) .567
87 85 .199
84 74 .058
1.3 (0.5) 1.3 (0.5) .799
35 46 .610
35 46 .540
1.7 (0.8) 1.9 (0.9) .607
47 76 .030
95 85 .063
3.7 (1.0) 3.8 (1.2) .456
30 63 .009
54 30 .079
35 35 .276
22 22 .182
24 15 .405
24 13 .315
5 7 .778
30 30 .726
57 70 .162arteOT and PWT,13,14 and this association persists even after
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June 20121658 Gardner et aladjusting for ABI.14 No group differences in the time to
minimum calf muscle StO2 or in the minimum value of calf
muscle StO2 indicates that the microcirculation in the calf
musculature during exercise is impaired to a similar extent
among groups and is unlikely to be a reason for different
descriptions of exertional leg pain obtained from the
SDCQ.
Atypical leg pain is defined as pain located in the
buttocks or thighs or pain that does not force the patient to
slow down or stop exercising. Furthermore, atypical leg
pain is characterized by not resolving within 10 minutes
after exercise. As such, it might be anticipated that the
atypical pain group would have prolonged time to mini-
mum calf muscle StO2 during exercise, indicating less rapid
oxygen desaturation of the calf musculature and a slower
recovery in calf muscle StO2. Calf muscle StO2 during and
after exercise was similar between those with claudication
and those with atypical leg pain, which suggests that irre-
spective of the symptoms, patients with PAD have similar
declines in microcirculation in the exercising, ischemic leg
muscles. Furthermore, when patients with leg pain on
Table II. Exercise measures during a graded treadmill test
three exertional leg symptom groups
Group 1a
(n  31)
Group 2b
(n  37)
Variables Mean (SD) Mean (SD) M
Exercise performance
Claudication onset time,
sec
233 (171) 171 (133)
Peak walking time, sec 463 (307) 352 (216)
Peak oxygen uptake, mL/
kg/min
13.0 (4.5) 12.6 (3.1)
Ischemic window, mm Hg
 min/m
0.52 (0.82) 0.74 (0.84) 
Calf muscle StO2
StO2 at rest, % saturation 53 (21) 55 (17)
Minimum StO2, %
saturation
15 (19) 18 (21)
Time to minimum StO2,
sec
254 (284) 170 (197)
Drop in StO2
Absolute, % saturation 38 (19) 37 (17)
Percentage, % 75 (26) 72 (30)
StO2 at peak walking time, %
saturation
19 (19) 22 (23)
Rate of decline in StO2 from
rest to minimum
exercise value, %
saturation/s
0.52 (0.60) 0.64 (0.62)
Recovery half-time of StO2,
sec
138 (155) 174 (157)
Recovery time of StO2, sec 224 (230) 311 (270)
Recovery time to maximal
StO2, sec
696 (297) 721 (252)
Maximum recovery StO2, %
saturation
85 (21) 81 (17)
aTypical leg pain.
bClaudication.
cLeg pain on exertion and rest.exertion that sometimes begins at rest are compared with patients with claudication, it might be anticipated that the
ormer group should have greater impairment in calf mus-
le StO2, particularly while at rest. This was not the case: the
alf muscle StO2 of the two groups was similar throughout
esting.
xercise performance comparisons
Leg symptoms. All patients experienced symptoms
uring the treadmill test consistent with claudication. Each
atient reported pain in the calf musculature that gradually
rogressed to maximal tolerable pain to end the test, and
ach patient reported pain relief 10 minutes of rest after
he treadmill test. Thus, claudication secondary to vascular
nsufficiency should be suspected in patients who complain
f any type of leg pain, until proven otherwise, regardless of
hether the pain description exactly matches that of classic
laudication. If high-risk patients with atypical leg pain are
ot further evaluated, many may go undertreated. Indeed,
n the current study, only 37 of 114 patients (32%) with
onfirmed PAD described exertional leg pain consistent
ith classic claudication according to the SDCQ. This
atients with peripheral artery disease (PAD) placed in
p 3c
46) Mean differences (95% CI)
(SD) P Group 1 vs 2 Group 2 vs 3
(117) .074 61 (12 to 135) 10 (45 to 64)
(275) .238 111 (16 to 238) 56 (166 to 54)
(3.2) .631 0.4 (1.5 to 2.2) 0.4 (1.0 to 1.8)
(1.68) .777 0.21 (0.19 to 0.62) 0.08 (0.68 to 0.52)
(23) .646 2 (11 to 7) 4 (5 to 14)
(20) .817 3 (13 to 7) 1 (8 to 10)
(244) .350 83 (34 to 200) 22 (120 to 77)
(22) .547 1 (8 to 10) 3 (5 to 12)
(31) .651 4 (10 to 17) 3 (11 to 16)
(22) .863 2 (13 to 8) 0.1 (10 to 10)
(0.46) .471 0.12 (0.42 to 0.18) 0.15 (0.09 to 0.38)
(124) .405 36 (114 to 42) 42 (21 to 105)
(174) .058 87 (212 to 38) 120 (20 to 219)
(265) .182 25 (158 to 108) 106 (9 to 220)
(24) .186 4 (5 to 13) 5 (4 to 14)in p
Grou
(n 
ean
162
408
12.2
0.66
51
17
192
34
69
22
0.50
132
191
615
76ercentage is at the upper end of the reported range of 10%
T
w
w
m
v
d
a
t
c
a
f
t
a
a
t
a
a
a
r
h
g
t
m
o
e
e
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 6 Gardner et al 1659to 35% of patients with PAD describing their symptoms
consistent with classic claudication.1,2 It may be surmised
that the percentage of patients with classic claudication
seen in vascular clinics, but who were not referred to the
study for evaluation, was even lower than 32%.
Treadmill exercise. The groups did not have signifi-
cantly different results for COT, PWT, peak oxygen uptake,
and ischemic window. This finding is in agreement with our
earlier results that exercise performance is not different in
patients with claudication, atypical leg pain, and leg pain on
exertion and rest.12 Collectively, these results suggest that
PAD symptom subtype has little effect on exercise perfor-
mance during a standardized treadmill test. Thus, patients
with varying symptoms have similar pain-mediated exercise
limitations and vascular compromise. From an exercise
rehabilitation standpoint, all symptomatic patients should
be considered for an exercise program to treat symptoms,
regardless of leg pain subtype.
6MWT, WIQ, and daily ambulatory activity. De-
spite no differences among the groups on calf muscle StO2
and exercise performance during standardized exercise,
significant group differences were found for subjective and
self-paced exercise tasks and for monitored daily ambula-
tory activity. In general, the patients with atypical exer-
tional leg pain had the most favorable measures for the
6MWT, self-reported ambulatory function, and daily am-
bulatory activity. Patients with atypical leg pain reported
the lowest rating of perceived exertion at completion of the
Table III. 6-Minute walk performance, daily ambulatory
Walking Impairment Questionnaire measures in patients w
leg symptom groups
Atypical leg
(n  31
Variables Mean (SD
6-Minute walk test
Pain-free distance, meters 202 (117
Total distance, meters 370 (102
Rating of perceived exertion, score 12.5 (2.8
Walked continuously for 6 min, % of subjects 68 (48)
Daily ambulatory activity
Maximum cadence, strides/min
1 minute 47.7 (6.0
5 minutes 32.4 (8.8
20 minutes 23.4 (16.
30 minutes 17.5 (7.4
60 minutes 13.0 (5.8
Peak activity index, strides/min 32.2 (8.0
Average cadence, strides/min 13.0 (3.1
Total strides, strides/d 4051 (210
Total activity time, min/d 309 (124
Walking Impairment Questionnaire, %
Distance score 42 (28)
Speed score 45 (20)
Stair climbing score 48 (28)
aDifferent than atypical leg pain group (P  .05).6MWT and the highest walking speed score on the WIQ. vhis latter result supports previous studies that found those
ith atypical leg pain have higher WIQ scores than those
ith claudication.7,11
Patients with atypical leg pain also had the highest
easures of daily ambulatory activity, supporting our pre-
ious observation that they had higher levels of monitored
aily physical activity than those with leg pain on exertion
nd rest.12 The unique aspect of the current activity data is
hat they provide information regarding daily ambulatory
adences and, thereby, the intensity of ambulation. The
verage daily cadence, the maximum cadences, ranging
rom 5 continuous minutes to 60 continuous minutes, and
he peak activity index were higher in the patients with
typical leg pain. These data indicate that the total daily
ctivity of patients with atypical claudication pain is higher
han that of the other groups, primarily due to ambulating
t faster paces throughout the day. It is possible that
typical leg pain is less uncomfortable, enabling patients to
mbulate faster.
The findings in the group with leg pain on exertion and
est are also worth noting. Even though this group had the
ighest ABI, indicating less severe PAD than the other two
roups, they also had the highest prevalence of obesity and
he highest BMI values. Their calf muscle StO2 and tread-
ill exercise performance measures were similar to the
ther groups, but not better, which suggests that obesity
xerts a negative influence on the microcirculation and
xercise performance that counteracts the potential ad-
ty recorded during a 7-day monitoring period, and
eripheral artery disease (PAD) placed in three exertional
Group
Claudication
(n  37)
Leg pain on exertion and rest
(n  37)
Mean (SD) Mean (SD) P
148 (79) 151 (118) .072
317 (104) 333 (102) .100
13.5 (2.0) 14.1 (2.4)a .017
42 (50) 59 (50) .087
44.5 (6.1) 44.8 (5.8) .061
27.4 (6.7)a 28.9 (7.9) .035
15.7 (5.3)a 17.4 (6.9)a .007
13.3 (4.8)a 14.6 (6.1) .020
9.9 (3.6)a 10.9 (4.7) .029
27.9 (6.3)a 28.9 (7.1) .040
11.1 (2.2)a 11.6 (2.3) .010
2901 (1380)a 3386 (1767) .032
254 (92) 283 (110) .128
26 (27) 37 (35) .083
30 (23)a 29 (25)a .006
34 (27) 33 (30) .056activi
ith p
pain
)
)
)
)
)
)
)
8)
)
)
)
)
9)
)antage of having milder PAD. This supports previous
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June 20121660 Gardner et alstudies reporting a negative effect of obesity on COT and
PWT30-33 and a negative effect of obesity on reactive hyper-
emia and transcutaneous oxygen tension32,34 through ele-
vated fasting glucose.32 Finally, no group differences in tread-
mill exercise performance in the current study corresponded
better with the calf muscle StO2 findings (ie, no differences
among groups) than with the ABI findings (ie, significant
difference among groups), which supports our previous
work that COT and PWT are more strongly associated with
the time to minimum calf muscle StO2 than with ABI.
13,14
Limitations
Patients who participated in this trial were volunteers
and may therefore represent those who were more inter-
ested in exercise, who had better access to transportation to
the program, and who had relatively better health than
PAD patients who did not volunteer. The cross-sectional
design comparing patients with different types of exertional
leg pain does not allow causality to be established, as it is
possible that patients in each group were different in daily
ambulatory activity and perceived ambulatory function be-
fore the development of symptoms.
The present findings are also limited to PAD patients
with a history of leg pain who are limited by their pain
during a standardized treadmill test, regardless of whether
the leg pain is typical or atypical of claudication. Thus, the
current findings cannot be generalized to patients with less
severe PAD (ie, asymptomatic PAD), or more severe symp-
toms (ie, critical leg ischemia), or to those who are limited
in their exercise performance by other significant comorbid
conditions.
There are limitations associated with the measurement
of calf muscle StO2 as previously described.
13 Although calf
muscle StO2 reflects a balance between oxygen delivery and
utilization, other factors may also contribute to the StO2
measurement. First, venous blood, which has low oxygen
saturation, may mix with capillary blood in the local tissue.
Second, myoglobin may partially contribute to the calf
muscle StO2 measurement. Finally, the subcutaneous fat
thickness directly under the probe may interfere with the
measure of calf muscle StO2. However, we believe these
limitations have minimal influence on calf muscle StO2, as
discussed earlier.13
There are limitations associated with the step activity
monitor. It is possible that the patients did not wear the
step activity monitor during portions of their waking hours,
thereby resulting in an underestimate of daily ambulation.
We believe this possibility is unlikely because long dura-
tions in which no active minutes were recorded during
daytime hours were rarely evident from the software
graphs. Another limitation is that the step activity monitor
does not quantify nonambulatory physical activity and
therefore underestimates to some extent the total amount
of daily physical activity accomplished.
CONCLUSIONS
All patients experienced symptoms consistent with clas-
sic claudication during a standardized treadmill test, re-ardless of their pain description. Each group with exer-
ional leg pain demonstrated similar impairments in calf
uscle StO2 and exercise performance during standardized
readmill exercise, but those with atypical exertional leg
ain were most active in the community setting and viewed
heir ambulatory function most favorably.
PAD patients with atypical leg pain have vascular-
ediated limitations in exercise performance during
tandardized treadmill testing similar to patients with
laudication and patients with leg pain on exertion and
est but have higher levels of daily ambulatory activity in
he community setting and higher perceived ambulatory
unction. From an exercise standpoint, the clinical sig-
ificance is that PAD symptom subtype obtained at the
nitial clinical presentation has little correlation with
xercise performance during standardized treadmill ex-
rcise. Thus, claudication secondary to vascular insuffi-
iency should be suspected in patients who complain of
ny type of leg pain, until proven otherwise.
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